Schering, the German pharmaceuticals group fighting off a €14.6bn ($17.4bn) hostile bid from local rival Merck, has added Dresdner Kleinwort Wasserstein to its defence team. Morgan Stanley is already advising.
A spokeswoman for DrKW confirmed the appointment.